Short answer

When designing orthopedic implants, consider composite materials that promote bioactivity, such as incorporating hydroxyapatite into metallic alloys, to enhance osseointegration.

Field
Final Production
Source
Acta Metallurgica Slovaca (2014)
Method
Experimental investigation and in-vitro testing.
Evidence
Strong effect

Adding hydroxyapatite (HAP) to Co-Cr-Mo alloy (ASTM F-75) transforms its inert surface into a bioactive composite capable of forming an apatite layer in simulated body fluid, improving its potential for orthopedic implants. This final production research insight is drawn from a 2014 study published in Acta Metallurgica Slovaca. Using Experimental investigation and in-vitro testing., researchers explored how this design variable affects real-world outcomes. The key design takeaway: When designing orthopedic implants, consider composite materials that promote bioactivity, such as incorporating hydroxyapatite into metallic alloys, to enhance osseointegration.

Study
Final ProductionHigh ImpactStrong effect

Incorporating Hydroxyapatite Enhances Co-Cr-Mo Alloy Bioactivity for Orthopedic Applications

Adding hydroxyapatite (HAP) to Co-Cr-Mo alloy (ASTM F-75) transforms its inert surface into a bioactive composite capable of forming an apatite layer in simulated body fluid, improving its potential for orthopedic implants.

Acta Metallurgica Slovaca · 2014

01

Key Findings

  • 01The addition of HAP to Co-Cr-Mo alloy successfully created a bioactive composite.
  • 02An apatite layer formed on the surface of the F-75/HAP composite after 18 days of immersion in phosphate buffered saline.
  • 03The formation of this apatite layer suggests improved biocompatibility and osteoconductivity.
02

Application

Design takeaway

When designing orthopedic implants, consider composite materials that promote bioactivity, such as incorporating hydroxyapatite into metallic alloys, to enhance osseointegration.

How to apply

When developing or selecting materials for bone-contacting implants, evaluate composite options that exhibit bioactivity, such as those incorporating hydroxyapatite or other osteoconductive phases.

Project actions

  • 01When choosing materials for a design project, research their known biological interactions.
  • 02Consider how material composition can be altered to achieve desired functional properties, like bioactivity.
03

Method & Evidence

AimTo investigate the effect of varying hydroxyapatite (HAP) content on the microstructure and in-vitro bioactivity of Co-Cr-Mo (ASTM F-75) alloy composites.
MethodExperimental investigation and in-vitro testing.
ProcedureCo-Cr-Mo (F-75) powder was mixed with 2, 6, and 10 wt.% of HAP, cold compacted at 550 MPa, and then sintered at 1100°C for 2 hours. The resulting composites were immersed in simulated body fluid (phosphate buffered saline) for up to 18 days to evaluate their bioactivity by observing apatite layer formation.
ContextBiomaterials development for orthopedic implants.

Variables

IV["Weight percentage of hydroxyapatite (2%, 6%, 10%)"]
DV["Microstructure of the composite","Formation of apatite layer (bioactivity)"]
CV["Base alloy composition (ASTM F-75)","Compaction pressure (550 MPa)","Sintering temperature (1100°C)","Sintering time (2 h)","Immersion time in simulated body fluid (up to 18 days)","Type of simulated body fluid (phosphate buffered saline)"]
04

Strengths & Limitations

Strengths

  • +Directly addresses the need to improve bioactivity of common biomaterials.
  • +Provides clear experimental procedure for creating and testing bioactive composites.

Limitations

The in-vitro environment does not fully replicate the complex biological conditions within the human body.

Reliability & validity

The study's validity is supported by the use of standard materials (ASTM F-75) and established testing methods (in-vitro immersion in SBF). Reliability would be enhanced by repeating the sintering and immersion processes multiple times for each HAP concentration and performing quantitative analysis of the apatite layer.

Think critically

How might the mechanical properties of the Co-Cr-Mo alloy be affected by the addition of hydroxyapatite, and would these changes impact its suitability for load-bearing orthopedic applications?

05

Design Principles

"Bioactive composite materials can improve the integration of implants with biological tissues."

This research demonstrates a practical method for enhancing the biocompatibility of established metallic biomaterials. By modifying the surface properties through material composition, designers can create implants that integrate better with bone tissue, potentially leading to improved patient outcomes and reduced revision surgeries.

06

What This Means for Your Design

Researchers mixed a common metal used for implants (Co-Cr-Mo) with a bone-like material (hydroxyapatite) and found that the mix became 'active' in a fake body fluid, forming a layer that helps bones grow onto it.

How to use in your project

  • 1.Reference this study when discussing the selection of biomaterials for orthopedic devices, highlighting the benefits of bioactive composites.
07

Add to My Project

08

Quick Cite

Paragraph starter

The development of bioactive composite materials, such as the F-75/HAP system investigated by Jamaludin et al. (2014), offers a promising avenue for enhancing the integration of orthopedic implants with host bone tissue. By incorporating hydroxyapatite, the inert Co-Cr-Mo alloy demonstrated an ability to form an apatite layer in simulated body fluid, indicating improved biocompatibility and osteoconductivity, which are critical factors for successful long-term implant performance.

09

Source

Acta Metallurgica Slovaca

MICROSTRUCTURE AND IN-VITRO TEST BIOACTIVITY BEHAVIOR OF Co-Cr-Mo (F-75)/HYDROXYAPATITE IN PHOSPHATE BUFFERED SALINE SOLUTION

journal · 2014

View source

Questions About This Research

What does the research say about incorporating hydroxyapatite enhances co-cr-mo alloy bioactivity for orthopedic applications?
When designing orthopedic implants, consider composite materials that promote bioactivity, such as incorporating hydroxyapatite into metallic alloys, to enhance osseointegration. Evidence: Acta Metallurgica Slovaca (2014).
Why does "Incorporating Hydroxyapatite Enhances Co-Cr-Mo Alloy Bioactivity for Orthopedic Applications" matter for design?
This research demonstrates a practical method for enhancing the biocompatibility of established metallic biomaterials. By modifying the surface properties through material composition, designers can create implants that integrate better with bone tissue, potentially leading to improved patient outcomes and reduced revision surgeries.
How can designers apply this research?
When designing orthopedic implants, consider composite materials that promote bioactivity, such as incorporating hydroxyapatite into metallic alloys, to enhance osseointegration.
What were the main findings?
The addition of HAP to Co-Cr-Mo alloy successfully created a bioactive composite.. An apatite layer formed on the surface of the F-75/HAP composite after 18 days of immersion in phosphate buffered saline.. The formation of this apatite layer suggests improved biocompatibility and osteoconductivity.
What research method was used?
Experimental investigation and in-vitro testing..
How strong is the evidence?
Evidence strength is rated Strong effect, based on a 2014 journal from Acta Metallurgica Slovaca.
What should I do differently in my next project?
When developing or selecting materials for bone-contacting implants, evaluate composite options that exhibit bioactivity, such as those incorporating hydroxyapatite or other osteoconductive phases.
What are the limitations?
The study was conducted in-vitro; long-term in-vivo performance and mechanical properties of the composite were not assessed.